Printer Friendly
The Free Library
21,440,732 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Lilly cited for deficient corrective actions.

Despite FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 investigator Ernest Bizjak's 2006 findings of "no significant issues" upon a pre-approval inspection of Tippecanoe Laboratories, Eli Lilly's Lafayette API (Application Programming Interface) A language and message format used by an application program to communicate with the operating system or some other control program such as a database management system (DBMS) or communications protocol.  manufacturing facility, his 483 noted one item: a lack of corrective actions A corrective action is a change implemented to address a weakness identified in a management system. Normally corrective actions are instigated in response to a customer complaint, abnormal levels if internal nonconformity, nonconformities identified during an internal audit or  when foreign contamination was found during a tank cleaning.

The single item on the 483 cited the company for taking no corrective action after an investigation of a deviation found that a bag tie, closure button and packing material fragments were found during the cleaning of a tank. Although the company's report on the deviation went into detail "about how the foreign contaminants would not affect the product quality," Lilly did not "outline any corrective actions that should be undertaken to prevent" any future contamination, the investigator noted.

In its letter of response to the 483, General Manager Lawrence McShane noted the company would communicate the "results of the deviation investigation, corrective actions taken and the FDA investigator's comments directly to the personnel involved through a training session that will be clearly documented." Further, the company stated it would revise its SOP on deviations "to include a minimum requirement of personnel communication and/or retraining re·train  
tr. & intr.v. re·trained, re·train·ing, re·trains
To train or undergo training again.



re·train
, as appropriate, for deviation investigations with no identified root cause and/or with low frequency."

The investigator noted that among the issues he discussed with the facility's management team was "storage of raw materials, intermediates and finished APIs in the firm's T18 warehouse," which had no temperature or humidity controls Humidity control

Regulation of the degree of saturation (relative humidity) or quantity (absolute humidity) of water vapor in a mixture of air and water vapor. Humidity is commonly mistaken as a quality of air.
. Although temperature and humidity had been monitored and some hold-time studies had been performed, Bizjak stated "that they should have data for the step five intermediate at accelerated conditions, since the T18 warehouse conditions can exceed the conditions that they currently have data for."

The close-out meeting also included discussion about the need for Lilly to document employee training taken as part of a corrective action, the EIR EIR n. popular acronym for environmental impact report, required by many states as part of the application to a county or city for approval of a land development or project. (See: environmental impact report)  stated.

Two issues noted on a 483 following the previous year's inspection were noted to have been corrected, the investigator concluded.

Eli Lilly Eli Lilly can refer to:
  • Eli Lilly and Company, a global pharmaceutical company
  • Colonel Eli Lilly (1839-1898), founder of Eli Lilly and Company
  • Eli Lilly (industrialist) (1885-1977), former president of Eli Lilly and Company
 & Co, Lafayette, IN, 7/25-8/3/06, Doc. 110070, $7 plus retrieval.

* The Checklist--Eli Lilly

* No actions for contamination prevention
COPYRIGHT 2008 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Human Drugs
Author:Mashaw, Rebecca
Publication:Validation Times
Date:Sep 1, 2008
Words:350
Previous Article:Documentation and testing procedures lacking at Hyaluron.
Next Article:Phillips Plastics passes inspection.
Topics:



Related Articles
Not following written SOPs cited at Syncor International.
Design inputs, software trip GE Medical Systems, France.
Medtronic Midas Rex drill motor tests may have allowed overheating; test acceptance validation cited.
Third party consultants play key role in consent decrees, but only a "Band-Aid" effort.
Medical devices.
Lilly receives two 483s in one month for sterile media fill failures.
Merck receives 54-item 483 for aseptic failures, failure to investigate.
Abbott warned for QS violations, poor validation.
Lilly may face more Zyprexa lawsuits after FDA letter.
FDA warns manufacturers about ADHD drug claims.

Terms of use | Copyright © 2013 Farlex, Inc. | Feedback | For webmasters | Submit articles